SMi’s 22nd Annual Pain Therapeutics Conference Conference 4 - 5 May 2022 Workshop: 6 May 2022 London, UK http://www.pain-therapeutics.co.uk/PJwl Sponsored by: CHDR Conference Chairman: Richard Malamut, Chief Medical Officer, Collegium Pharmaceutical, Inc Novel Compounds and Treatments for Pain: Opioids and the Alternatives  SMi’s 22nd Pain Therapeutics Conference will cover the leading advances in pain therapeutics, […]

SMi’s 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference: 9 – 10 May 2022 London, UK Website: www.highlypotentapi.com/WLPJ Chaired by Justin Mason-Home, Owner, Director, HPAPI Project Services Limited  Ensuring Risk-Based, Safety-Driven, High-Quality Operation SMi is proud to present its 6th Annual Highly Potent Active Pharmaceutical Ingredients, taking place on the 9 – 10 May 2022. […]

LEAP HR: Life Sciences West is your best opportunity to hear how scaling life sciences organizations are implementing the experimental people strategies required to drive innovation and growth whilst operating in a tight talent market. Step inside 30+ case studies of the radical, future-focused HR thinking that will empower you to transform your impact and […]

Adenosine-pathway therapies have produced a plethora of promising clinical trial data that is being met with refreshed excitement, enthusiasm, and R&D investment for adenosine-pathway targets. With reinvigorated confidence in the field, join fellow industry and academic thought leaders at the inaugural Adenosine-Pathway Targeted Cancer Immunotherapy Summit. This is the only comprehensive forum dedicated to optimizing […]

Integrate Advanced 3D Models with Scalability & Predictability to Supercharge Your Modeling Toolbox & Enhance Clinical Confidence Following the FDA’s announcement of ‘Alternative Methods Working Group’ in the summer, 2021, Roche’s newly opened pRED Innovation Center in Basel, and exciting data from Recce Pharma’s anti-infective candidate using organoids, the 7th Annual 3D Tissue Models Summit […]

Following innovative technological breakthroughs and the FDA’s Emerging Technology Program, the pharmaceutical industry is experiencing a renaissance period with an unprecedented level of investments in new builds and next-generation technology to support novel pipeline progression. The ability to commission a modern, flexible, compliant facility on time and a budget have never been so critical to […]

SMi Group Introduces the 4th Annual… Injectable Drug Delivery Conference 2022 11th May to 12th May 2022, London, United Kingdom www.injectable-drug-delivery.com/ Innovations in Formulation and Device Design for Enhanced Subcutaneous Delivery As Part of Europe’s leading Injectable conference series, we will assess innovations in drug product formulation and biologics, new technologies in device design and the use […]

The 4th Microbiome Movement - Maternal & Infant Health Summit is returning, in person, on May 17-19, 2022 with the goal of uniting expert industry and academic minds to tackle the biggest challenges in the understanding, targeting and treatment creation for the maternal and infant microbiome. This summit is the only place where you will find such a collaborative and engaged group of speakers and attendees with a diverse group […]

The pandemic response has accelerated technology adoption in clinical trials, but we have neglected patient needs by failing to develop co-created, data-driven, standardised and accountable trial designs.  In the face of rethinking clinical strategy, our mission is clear: it’s time to develop a better system. We must establish new industry-wide benchmarks now, leverage recent digital […]

As Biopharma turn their focus to autoimmune drug development, there has been an explosion of interest and investment into Treg directed therapies. Promising proof-of-concept data and early clinical read outs have fueled further hype, and the industry now looks to demonstrate efficacy. The 4th Treg Directed Therapies Summit returns to Boston this May, bigger and […]

Bringing together a senior audience of cutting-edge device manufacturers, and featuring a unique program focused on real-life use cases, the 2022 Medical Device Software Development Summit offers you a toolkit for designing compliant, innovative, and secure medical device software, enabling you to move one step ahead of emerging trends. So whether you’re a part of […]

Deliver enduring behavioral change with agile, personalized engagement  Precise, Personalized and Proactive- the future of customer engagement is a digitally enabled, hybrid omnichannel strategy.   Heard that all before?     From measuring clicks to measuring behaviour change, the way we think about customer preference has forever been changed. Across marketing, commercial, and medical, the skills we need to deliver on changing […]

Precise, Personalized and Proactive- the future of customer engagement is a digitally enabled, hybrid omnichannel strategy. Heard that all before? From measuring clicks to measuring behaviour change, the way we think about customer preference has forever been changed. Across marketing, commercial, and medical, the skills we need to deliver on changing HCP expectations are aligning. Now […]

With novel RNA-based modalities having seen extraordinary development in the last 18 months, there has never been a more important time for the RNA community to unite, share learnings and accelerate the field towards successful proof of concept and effective therapeutic development. Stay ahead of the curve with novel RNA therapeutics and vaccines that offer […]

4th Annual Cell Engager Summit  May 24-26, 2022 | Boston, MA The 4th Annual Cell Engager Summit returns to bring you the latest on effectively targeting lymphocyte-restricted tumor-associated antigens to treat hematological malignancies, including CD19, CD20, BCMA, CD33, and CD123. This must-attend meeting will provide a comprehensive understanding of the development of multi-specific cell engaging therapeutics in liquid and […]

It has long been understood that the Hippo pathway plays a critical role in the development of a wide range of diseases. Although once seen as an elusive pathway, emerging novel data and research is forging a wider and more developed mechanistic understanding of it. New avenues have been opened to evolve the landscape of […]

As ADCs continue to see clinical success, and as drug design becomes more complex, regulatory scrutiny to ensure product quality is increasing. The trailblazing ADC Analytical Development Summit is the first and only industry focused meeting dedicated to addressing the unique challenges faced by analytical, CMC, QC, process development and protein characterization experts working on ADCs. Covering […]

Uncover the Robust Analytical Methods to Guarantee Safe, High Quality, Consistent & Efficacious Gene Therapy Products In the context of unprecedented gene therapy investment and clinical progress, with mounting regulatory scrutiny, Gene Therapy Analytical Development Europe will unite innovative biotech and pharma organisations to develop robust analytical tools to guarantee the consistency, quality, and safety […]

Integrate the Patient Voice to Develop Safer & More Effective Gene Therapies That Are Meaningful to Patients As investment in gene therapies continues to grow rapidly, more effectively engaging patients throughout development has become a priority for any company serious about building safer and more meaningful gene therapy programs. In this context, the 2nd Annual […]

SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA SESSING DEVICE DEVELOPMENT AND REGULATION FOR ADVANCED INNOVATION SMi is delighted to announce the 6th annual Pre-Filled Syringes West Coast conference, to be held in San Diego. As part of SMi’s leading series of drug delivery device […]

Outcomes for HER2-expressing breast cancer are patients constantly improving; advancements in diagnostics, trial design and innovative drug design are at an all-time high; complementing the newly accessible HER2 ‘low' space and wider range of tumor indications; the last year has given us more progress in HER2-targeted therapies than ever before. As such, the HER2-Targeted Therapies Summit returns […]

Returning in 2022, the 2nd Tumor Myeloid-Directed Therapeutics Summit is the only industry-focused meeting dedicated to unlocking novel therapeutic potential through the myeloid compartment. This is your ultimate forum to identify, validate, and clinically progress myeloid targets to expand the oncologists toolkit and realize better responses by engaging myeloid anti-tumor function. Designed for experts working directly on myeloid-directed […]

Biotech companies are paving the way to displace the cochlear implant and cater for the huge unmet need in hearing and balance disorders. The field is booming with excitement, with pharma companies increasing investment into these pipelines in the race to successfully reverse hearing damage. Returning as an in-person event to Boston, the 2nd Inner Ear […]

CPhI & P-MEC China is Asia's leading pharmaceutical show for trading, knowledge sharing and networking. It spans all industry sectors along the pharmaceutical supply chain and is your one-stop platform to grow business in the 2nd largest pharma market in the world. CPhI & P-MEC China 2022, with the co-located shows FDF, bioLIVE, Pharma Excipients, […]

The 7th Microbiome Movement - Drug Development Summit returns to Boston at a pivotal time. As the microbiome therapeutic space matures, with more indications being pursued and more companies conducting trials, the focus of this event - now in its 7th year - is evolving to showcase these new studies. With this progress however comes new challenges, and we’re excited […]

Built with biopharmaceutical industry insights, this in-person conference will delve into the latest advancements of non-viral RNA delivery systems such as LNPs, exosomes and polymers to set the scene for the translation of targeted, safe and durable delivery systems for RNA therapeutics and vaccines with improved formulation, distribution and tissue-specificity. Don't miss 20+ pioneering speakers from large […]

Are you using TCRs to target solid tumors yet? With Immunocore having achieved commercialization for the first TCR therapy and Adaptimmune hot on their tail, 2022 is fast becoming the year for TCRs. Join the TCR-based Therapies for Solid Tumors Summit (June 27-29) to gain knowledge to accelerate the clinical development and improve the safety […]

Undoubtedly, the past two years have changed the pharma industry forever; new modalities are dominating pharma pipelines, drugs are increasing in potency, and the restrictions around product quality are tighter than ever before. It is integral that the HPAPI community comes together to apply expertise in ensuring operator safety, alongside product quality, to the future […]

The 8th Annual Microbiome Connect: Europe 2022 dedicated to showcasing the leading drug development and consumer product platforms applying live microbial consortia, engineered microbes, and microbial-derived metabolites for therapeutic and health applications in patients and consumers. As the first EMA approved microbiome-targeted therapeutics emerge on the horizon, drug developers will have to opportunity to benchmark […]

Accelerating Europe's Progress in CNS Gene Therapy Navigating Europe-Specific Challenges & European Regulators Requirements; Optimizing Preclinical Research in Neurological Models & Revolutionizing Gene Therapy Delivery to CNS Targets in the Clinic As programs advance globally, the 3rd Annual Gene Therapy for Neurological Disorders Europe meeting is the industry’s definitive forum dedicated to showcasing the European […]